𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in nod mice

✍ Scribed by Reiko Yasunami; Jean-FrançOis Bach


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
429 KB
Volume
18
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Nicotinamide prevents the development of
✍ O'Brien, Bronwyn A.; Harmon, Brian V.; Cameron, Donald P.; Allan, David J. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

The development of diabetes in non-obese diabetic (NOD) mice, which normally takes between 3 and 7 months, can be accelerated by cyclophosphamide (CY) injections, with rapid progression to diabetes within only 2±3 weeks. This insulin-dependent diabetes mellitus (IDDM) can be prevented or delayed in

Effects of heterologous antilymphocyte a
✍ Kenneth P. Judd; Kristina Stephens; John J. Trentin 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB 👁 2 views

Continuous antilymphocyte serum therapy of AKR mice led to accelerated inortality from spontaneous lymphoma in one experiment. In a repeat experiment, accelerated splenic enlargement, presumably leukemic, occurred, but time of mortality from leukemia did not significantly differ from controls. Conti

Regulation of delayed-type hypersensitiv
✍ H. K. Gill; F. Y. Liew 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

## Abstract A previous study (__Eur. J. Immunol.__ 1977. __7__: 714) has shown that mice injected intravenously (i.v.) with 1 × 10^9^ sheep red blood cells (SRBC) produce cells which suppress delayed‐type hypersensitivity (DTH). These suppressor cells are Θ‐positive, antigen‐specific and act via a

Inhibitory effect of the peptide epitalo
✍ Vladimir N. Anisimov; Vladimir KH. Khavinson; Mauro Provinciali; Irina N. Alimov 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 133 KB 👁 2 views

Female FVB/N HER-2/neu transgenic mice from the age of 2 months were subcutaneously injected with saline, the peptide Epitalon(R) (Ala-Glu-Asp-Gly) or with the peptide Vilon(R) (Lys-Glu) in a single dose of 1 microg/mouse for 5 consecutive days every month. Epitalon treatment reduced the cumulative